Health12 years ago
Novartis Wins Approval for First U.S. Biosimilar Drug
(Reuters) – U.S. regulators on Friday gave a green light to sales of the country’s first “biosimilar,” or copied version of a biotechnology drug, by approving Novartis’ white...
